期刊文献+

对氧磷酶1和脂蛋白磷脂酶A_2与冠心病的相关性 被引量:4

Studies on Association of PON1 and LP- PLA_2 in Coronary Heart Disease
下载PDF
导出
摘要 目的探讨冠心病患者血清对氧磷酶1(PON1)与脂蛋白磷脂酶A_2(LP-PLA_2)活性与冠脉病变支数及斑块稳定性的相关性。方法入选88例冠心病患者为研究组,同期行冠状动脉造影术(CAG)排除冠心病的32例患者为对照组。检测两组患者血清PON1、LP-PLA_2活性,对PON1、LP-PLA_2活性与冠状动脉病变支数及斑块稳定性进行相关性分析。结果冠心病患者血清PON1活性明显低于对照组(P<0.05);活性均值随冠状动脉病变支数增加而降低(P<0.05);在斑块不稳定组PON1活性明显低于斑块稳定组(P<0.05)。冠心病患者血清LP-PLA_2活性均值明显高于对照组(P<0.05),随冠状动脉病变支数增加而升高(P<0.05),且与患者总胆固醇、低密度脂蛋白水平呈正相关。结论血清PON1及LP-PLA_2活性与冠心病的发生及冠状动脉病变支数有相关性,PON1活性降低可作为冠状动脉斑块趋于不稳定的观察指标。 Objective To study the relationship between serum PON1 and LP-PLA2 activity of coronary artery lesions and plaque stability in patients with coronary heart disease. Methods According to the coronary angiography results, the patients were divided into coronary heart disease group(n=88) and control(n=32).Serum PON1 and LP-PLA2 activity among groups were compared.Relationship between PON1,LP-PLA2 activity and coronary lesions degree and plaque stability was analysed. Results The serum PON1 activity of coronary heart disease group was significantly lower than the control group(P〈0.05). PON1 activity decreased with increasing coronary lesion count(P〈0.05). The unstable plaque group was obviously lower than that of PON1 activity in the stable plaque group(P〈0.05). LP-PLA2 activity levels in the team significantly were higher than the control group(P〈0.05). LP-PLA2 activity increased with increasing coronary lesion count(P〈0.05). LP-PLA2 activity was positively correlated with total cholesterol and LDL levels. Conclusion Serum PON1 and LP-PLA2 activity correlated with the incidence of coronary heart disease and coronary artery lesion count. PON1 activity can be used as observation index of coronary plaque stability.
出处 《医学研究杂志》 2016年第3期108-111,共4页 Journal of Medical Research
基金 上海申康市级医院适宜技术推广应用项目(SHDC12012210) 上海市宝山区科技发展基金资助项目(12-E-63)
关键词 对氧磷酶1 脂蛋白磷脂酶A2 冠心病 PON1 LP-PLA2 Coronary heart disease
  • 相关文献

参考文献11

  • 1杨盛,张菲斐,韩战营,邱春光,黄振文.冠心病患者血清对氧磷酶1活性与糖化血红蛋白水平及冠状动脉病变的关系[J].中国动脉硬化杂志,2012,20(4):351-355. 被引量:6
  • 2Carza CA, Moutori VM, McCounell JP. Association between lipopro-tein associated phospholipase A2 and cardiovascular disease:a system- atic review [ J]. Mayo Clin Proc,2007,82 (2) : 159 - 165.
  • 3Zalewski A, Macphee C. Role of lipoprotein - associated phospho- lipase A2 in atheroschrosis: biology, epidemiology, and possible ther- apeutic target [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25 (5) : 925 - 931.
  • 4European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al. ESC/EAS guidelines for the manage- ment of dyslipidaemias : The Task Force for the management for dys- lipidaemias of the European Society of Cardiology (ESC) and the Eu- ropean Atherosclerosis Society (EAS) [ J]. Eur Heart J, 2011,32 (14) :1769 - 1818.
  • 5薛巧玲.对氧磷酶1与糖尿病合并冠心病关系的探讨[J].中外医疗,2012,31(20):44-45. 被引量:2
  • 6Daniil G, Phedonos AA, Holleboom AG, et al. Characterization of antioxidant/anti - inflammatory properties and apoA - I - containing suhpopulatious of HDL from family subjects with monogenic low HDL disorders[J]. Cliu Chim Acta, 2011,412(13 - 14) :1213 - 1220.
  • 7Yilmaz H, Sayar N,Yilmaz M, et al. Serum paraoxonase 1 activity in women with metabolic syndrome [ J]. Kardiol Pol, 2010, 68 ( 11 ) : 1219 - 1224.
  • 8Cao Y, Stafforini DM, Zimmerman GA, et al. Expression of plasma platelet - activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation [ J ]. J Biol Chem, 1998,273 ( 7 ) : 4012 - 4020.
  • 9张林娜,侯静波.脂蛋白相关磷脂酶A2与冠心病[J].国际心血管病杂志,2013,40(3):136-138. 被引量:13
  • 10Epps KC, Wilensky RL. LP - PLA2 - a novel risk factor for high risk coronary and carotid artery disease [ J ]. J Intern Med, 2011, 269 (1) :94 -106.

二级参考文献30

  • 1孙亚威,尚可,郭建政.对氧磷酯酶1与老年2型糖尿病患者血管并发症的关系研究[J].中国全科医学,2005,8(20):1669-1670. 被引量:9
  • 2于碧莲,赵水平.对氧磷酶1与动脉粥样硬化的研究进展[J].中国动脉硬化杂志,2005,13(5):655-658. 被引量:7
  • 3朱惠莲,夏敏,唐志红,侯孟君,凌文华.Ox-LDL通过LOX-1双重调节血管内皮细胞炎性分子的表达[J].中国病理生理杂志,2007,23(8):1464-1469. 被引量:11
  • 4Aviram M, Hardak E, Vaya J,et al.Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activ- i ties[J]. Circulation, 2000.101 (21 ) :2510- 2517.
  • 5Mackness MI,Arrol S,Mackness B,et al.Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation[J].Lancet,1997,349(9055):851-852.
  • 6Soran H,Younis NN,Charlton-Menys V,et al.Variation in paraoxonase-1 activity and athero- sclerosis[J].Curr Opin Lipidol,2009,20(4):265-274.
  • 7Zalewski A,Macphee C. Role of lipoprotein-associated phos-pholipase A2 in atherosclerosis: biology,epidemiology, andpossible therapeutic target [ J ]. Arterioscler Thromb VaseBiol, 2005, 25 .5):923-931.
  • 8Mallat Z,Lambeau G,Tedgui A, et al. Lipoprotein-associated andsecreted phospholipases A2 in cardiovascular disease: roles asbiological effectors and biomarkers [J]. Circulation, 2010.122(21): 2183-2200.
  • 9Packard CJ . O, Reilly DS,Caslake MJ, et al. Lipoprotein-associated phospholipase A2 as an independent predictor ofcoronary heart disease[J]. N Engl J Med, 2000,343 (16):1148-1155.
  • 10Daniels LB, LaughlinGA,Sarno MJ,et al. Lipoprotein-associated phospholipase A2 is an independent predictor ofincident coronary heart disease in an apparently healthy olderpopulation[J]. J Am Coll Cardiol, 2008,51 .9) : 913-919.

共引文献16

同被引文献37

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部